Evidence map›Paper›PMID 32901374›Full record

ReviewIntensive care medicine2020

Use of nasal high flow oxygen during acute respiratory failure.

Jean-Damien Ricard, Oriol Roca, Virginie Lemiale, Amanda Corley, Jens Braunlich, Peter Jones, Byung Ju Kang, François Lellouche, Stefano Nava, Nuttapol Rittayamai and 3 more

3 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Intensive care medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 98 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 4 pooled it
18.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05210881 completednot on this map

Weaning From Nasal High Flow Therapy: an Explorative Study Assessing the Usefulness of the ROX Index to Predict Outcome of the Weaning Process in Combination With a Withdrawal Trial

TypeobservationalSponsorHôpital Louis MourierRan2019 to 2021Enrolled62ConditionsRespiratory Distress Syndrome, Adult, Acute Hypoxemic Respiratory Failure, Acute Respiratory Distress Syndrome, Weaning Failure
NCT05401474 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Assessing Recruitability for Flow Individualization in Patients Treated With Nasal High Flow: a Physiological Study (The iFLOW Study)

TypeinterventionalSponsorHospital Universitari Vall d'Hebron Research InstituteRan2022 to 2023Enrolled26ConditionsHigh-Flow Nasal Cannula, Oxygen Therapy, Acute Respiratory Failure, Respiratory FailureArmsHigh Flow Nasal Cannula at 30L/min, High Flow Nasal Cannula at 45L/min, High Flow Nasal Cannula at 60L/min
NCT06204276 nacompletednot on this mapstarted 2024, after this paper: background citation

The Physiologic Effects of Asymmetrical Versus Conventional High-flow Nasal Cannula in Acute Respiratory Failure. A Randomized Crossover Study.

TypeinterventionalSponsorSiriraj HospitalRan2024 to 2024Enrolled40ConditionsAcute Hypoxemic Respiratory Failure, Acute Hypercapnic Respiratory FailureArmsExperimental: Asymmetrical high-flow nasal cannula, Active comparator: Conventional high-flow nasal cannula
3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 4 syntheses or guidelines pooled it, 253 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 13 institutions in 10 countries.

Jean-Damien RicardMedico-surgical ICU, Assistance Publique - Hôpitaux de Paris, DMU ESPRIT, Médecine Intensive Réanimation, Hôpital Louis Mourier, 92700, Colombes, France. jean-damien.ricard@aphp.fr.ORCID 0000-0003-1828-2299
Oriol RocaCritical Care Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
Virginie LemialeMedical ICU Saint Louis Hospital, APHP, Paris, France.
Amanda CorleyCritical Care Research Group, The Prince Charles Hospital, Chermside, Australia.
Jens BraunlichDepartment of Respiratory Medicine, University of Leipzig, Liebigstraße 20, 04103, Leipzig, Germany.
Peter JonesSchool of Medicine, University of Auckland, Auckland, New Zealand.
Byung Ju KangDepartment of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
François LelloucheQuebec Heart and Lung Institute, Laval University, Québec City, QC, Canada.
Stefano NavaDepartment of Clinical, Integrated, and Experimental Medicine (DIMES), Respiratory and Critical Care, Sant'Orsola Malpighi Hospital, Bologna, Italy.
Nuttapol RittayamaiDivision of Respiratory Diseases and Tuberculosis, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Giulia SpoletiniDepartment of Respiratory Medicine, St James's University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK.
Samir JaberSaint Eloi ICU, Montpellier University Hospital and PhyMedExp, INSERM, CNRS, 34000, Montpellier, France.
Gonzalo HernandezIntensive Care Medicine, University Hospital Virgen de la Salud, Toledo, Spain.
Assistance Publique – Hôpitaux de Paris · FRCentre National de la Recherche Scientifique · FRHospital Virgen de la Salud · ESInserm · FRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITSiriraj Hospital · THThe University of Queensland · AUUlsan College · KRUniversitat Autònoma de Barcelona · ESUniversité Laval · CAUniversity of Applied Sciences Emden Leer · DEUniversity of Auckland · NZUniversity of Leeds · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasal high flow (NHF) has gained popularity among intensivists to manage patients with acute respiratory failure. An important literature has accompanied this evolution. In this review, an international panel of experts assessed potential benefits of NHF in different areas of acute respiratory failure management. Analyses of the physiological effects of NHF indicate flow-dependent improvement in various respiratory function parameters. These beneficial effects allow some patients with severe acute hypoxemic respiratory failure to avoid intubation and improve their outcome. They require close monitoring to not delay intubation. Such a delay may worsen outcome. The ROX index may help clinicians decide when to intubate. In immunocompromised patients, NHF reduces the need for intubation but does not impact mortality. Beneficial physiological effects of NHF have also been reported in patients with chronic respiratory failure, suggesting a possible indication in acute hypercapnic respiratory failure. When intubation is required, NHF can be used to pre-oxygenate patients either alone or in combination with non-invasive ventilation (NIV). Similarly, NHF reduces reintubation alone in low-risk patients and in combination with NIV in high-risk patients. NHF may be used in the emergency department in patients who would not be offered intubation and can be better tolerated than NIV.

Indexed as

Noninvasive VentilationRespiratory Distress SyndromeRespiratory InsufficiencyHumansIntubation, IntratrachealOxygenOxygen Inhalation TherapyOxygenAcute respiratory failureARDSHigh flow oxygenIntubationNasal canulaPalliative care

Identifiers

PMID32901374
PMCPMC7478440
OpenAlexW3084264253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.